1
Feb

Postdoctoral Position in Precision Oncology Data Science

Official File: Biotech Data Scientist Postdoc – Job Posting The Kuhn-Hicks laboratory at USC is a leader in mathematical oncology for predictive mapping of cancer progression and treatment response. The laboratory uses clinical, demographic, and single cell morpho-proteo-genomic data to build predictive models to aid in improving patient care and outcomes. Our rapidly growing team is...
Read More
22
Jan

Should Research-grade Genomic Data be Returned to Patients?

While literature in clinical practice and patient rights suggests that study participants should have access to their genomic data, IRBs do not currently include mechanisms to facilitate effective and ethical collection of patient data across institutions and dissemination back to patients. Professor Kuhn and colleagues discuss the rights of patients to access their genomic data and...
Read More
28
Nov

How fear motivated our very own Peter Kuhn toward his vocation

In this feature story, Professor Kuhn shares his personal journey of how his mother’s diagnosis drove him to leave physics and tackle the challenges facing cancer biomedicine. He now leads the Convergent Science Initiative in Cancer (CSI-Cancer) at the USC Michelson Center for Convergent Bioscience where cutting-edge tools are being developed to improve outcomes for...
Read More
19
Jul

New tools, same goal: Technology akin to GPS apps could enable patients to map out their disease treatment and response

New research projects at the Kuhn-Hicks laboratory aim to develop computational technologies to map cancer evolution and predict treatment response. Through collaboration with the FDA on breast cancer) and funding by the Adelson Medical Research Foundation for multiple myeloma, the goal of these projects is to deploy novel machine learning and spatiotemporal models that would assist clinicians...
Read More
19
Jul

Featured in The Guardian: Fitness trackers could help doctors predict patient’s response to chemotherapy

A recent article in The Guardian highlights research from our lab on how fitness technologies are being used to monitor and predict how patients respond to chemotherapy. Led by Keck School of Medicine’s Dr Jorge Nieva, our clinical collaborator, the work emphasizes the efforts to use fitness trackers as objective measures for patient’s quality of...
Read More
28
Feb

USC Michelson Center for Convergent Bioscience scientists use metal-detection technique to map cancer cells at the molecular level

The Kuhn-Hicks laboratory are using metal-tagged antibodies to map the proteins expressed on cancer cells circulating in the blood and in the bone marrow from a prostate cancer patient.  The study, published in January by Convergent Science Physical Oncology, describes the approach of using an imaging mass cytometer to quantitate and localize 35 different protein markers...
Read More
30
Nov

New Educational Track to Train Undergraduates on Health Innovation to Help Patients Achieve Better Outcomes

USC’s Convergent Science Initiative in Cancer and the USC Jimmy Iovine and Andre Young Academy have developed a new interdisciplinary undergraduate track to launch in the fall of 2019. Students in this new educational track will interact with physicians, scientists, patients and graduate students to develop innovative health solutions. Click here to read more.